Nanosonics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nanosonics Ltd (NAN)
Nanosonics Ltd stock price live, this page displays ASX NAN stock exchange data. View the NAN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nanosonics Ltd real time stock price chart below.
What Is the Nanosonics Ltd Stock Price Today?
The Nanosonics Ltd stock price today is 3.05.
What Is the Stock Symbol for Nanosonics Ltd?
The stock symbol for Nanosonics Ltd is "NAN."
What Stock Exchange Does Nanosonics Ltd Trade On?
Nanosonics Ltd is listed and trades on the Sydney stock exchange.
Is Nanosonics Ltd a Good Stock to Buy?
Determining whether Nanosonics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NAN quote. (ISIN: AU000000NAN9)
What Is the Nanosonics Ltd Stock Price Today?
The Nanosonics Ltd stock price today is 3.05.
What Is the Stock Symbol for Nanosonics Ltd?
The stock symbol for Nanosonics Ltd is "NAN."
What Stock Exchange Does Nanosonics Ltd Trade On?
Nanosonics Ltd is listed and trades on the Sydney stock exchange.
Is Nanosonics Ltd a Good Stock to Buy?
Determining whether Nanosonics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NAN quote. (ISIN: AU000000NAN9)
Sydney
Currency in AUD
3.05
-0.63(-17.12%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.75
3.19
52 wk Range
2.75
4.77
Unusual trading volume
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.753.19
52 wk Range
2.754.77
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
NAN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
4.23
Upside
+38.61%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Nanosonics receives Investment Bank Analyst Rating Update- Investing.com
Pro
Nanosonics receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Nanosonics receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Nanosonics receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
5 Buy
3 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 4.23
(+38.61% Upside)
Nanosonics Ltd Earnings Call Summary for H2/2026
- Nanosonics FY26 revenue rose 6% to AUD 211.5M on constant-currency basis; EBIT up 21% to AUD 21.6M, but shares fell 14% on FY27 margin concerns
- FY27 guidance: revenue AUD 220-228M (8-12% growth), gross margin to fall to 74-76% from 76.9% due to tariffs and CORIS launch costs
- CORIS platform secured UK, Europe, Australia approvals and first FDA clearance; launch planned H1 FY27 internationally, US later in year
- Core trophon business placed record 4,230 units (up 9%) and 1,980 North America upgrades; trophon-only EBIT reached AUD 56.5M (up 16%)
- Company announced AUD 40M share buyback for FY27; operating expenses to rise to AUD 156-163M as CORIS investment peaks with no further step-up expected
Last Updated: 2026/08/25, 04:06
Read Full TranscriptEarnings
Latest Release
Feb 23, 2026
EPS / Forecast
0,03 / 2,07
Revenue / Forecast
102,23M / 94,85M
Compare NAN to Peers and Sector
Metrics to compare | NAN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNANPeersSector | |
|---|---|---|---|---|
P/E Ratio | - | 14.5x | −0.4x | |
PEG Ratio | - | 0.07 | 0.00 | |
Price/Book | - | 2.3x | 2.6x | |
Price / LTM Sales | - | 1.7x | 3.1x | |
Upside (Analyst Target) | 35.6% | 110.9% | 49.3% | |
Fair Value Upside | Unlock | 12.9% | 6.7% | Unlock |
Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infection control and decontamination products and related technologies. In addition, it is involved in the research, development, and commercialization of the CORIS system, an automated technology designed to transform flexible endoscope reprocessing. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Nanosonics (NAN) Stock Price Today?
The Nanosonics stock price today is 3,05 AUD.
What Stock Exchange Does Nanosonics Trade On?
Nanosonics is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Nanosonics?
The stock symbol for Nanosonics is "NAN."
What Is the Nanosonics Market Cap?
As of today, Nanosonics market cap is 912,45M AUD.
What Is Nanosonics's Earnings Per Share (TTM)?
The Nanosonics EPS (TTM) is 0,07.
From a Technical Analysis Perspective, Is NAN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Nanosonics Stock Split?
Nanosonics has split 0 times.
How Many Employees Does Nanosonics Have?
Nanosonics has 470 employees.
What is the current trading status of Nanosonics (NAN)?
As of Aug 25, 2026, Nanosonics (NAN) is trading at a price of 3,05 AUD, with a previous close of 3,05 AUD. The stock has fluctuated within a day range of 2,75 AUD to 3,19 AUD, while its 52-week range spans from 2,75 AUD to 4,77 AUD.
What Is Nanosonics (NAN) Price Target According to Analysts?
The average 12-month price target for Nanosonics is 4,23 AUD, with a high estimate of 5.55 AUD and a low estimate of 3.5 AUD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +38,61% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.